Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS
· Delayed Price · Currency is USD
0.4900
-0.0100 (-2.00%)
Jun 13, 2025, 12:25 PM EDT
Pharma-Bio Serv Cash Flow Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2015 - 2019 |
| Net Income | -0.5 | -0.78 | 1.31 | 1.01 | -2.09 | 2.05 | Upgrade
|
| Depreciation & Amortization | 0.19 | 0.18 | 0.19 | 0.19 | 0.07 | 0.09 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -0.01 | -0.01 | Upgrade
|
| Stock-Based Compensation | 0.04 | 0.05 | 0.05 | 0.07 | 0.06 | 0.04 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | 5.25 | - | Upgrade
|
| Other Operating Activities | -0.2 | -0.25 | -0.32 | - | -1.96 | - | Upgrade
|
| Change in Accounts Receivable | -0.29 | 1.46 | 1.09 | -0.46 | -0.13 | -0.94 | Upgrade
|
| Change in Other Net Operating Assets | -0.96 | -1.23 | -0.43 | -0.21 | -0.38 | 0.29 | Upgrade
|
| Operating Cash Flow | -1.72 | -0.57 | 1.89 | 0.59 | 0.8 | 1.51 | Upgrade
|
| Operating Cash Flow Growth | - | - | 219.17% | -26.39% | -46.85% | - | Upgrade
|
| Capital Expenditures | -0.16 | -0.16 | -0.01 | -0.02 | -0.01 | -0.06 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.06 | 0.03 | Upgrade
|
| Investment in Securities | 4.55 | -1.2 | -4.21 | - | - | - | Upgrade
|
| Other Investing Activities | - | - | - | - | 1.25 | - | Upgrade
|
| Investing Cash Flow | 4.39 | -1.36 | -4.22 | -0.02 | 1.3 | -0.03 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 1.93 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | - | 1.93 | Upgrade
|
| Repurchase of Common Stock | -0 | -0.01 | -0.03 | -0.08 | -0.03 | -0 | Upgrade
|
| Common Dividends Paid | -1.72 | -1.72 | -1.72 | -3.45 | -1.73 | -1.73 | Upgrade
|
| Financing Cash Flow | -1.73 | -1.73 | -1.76 | -3.53 | -1.75 | 0.2 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.05 | -0.02 | 0.07 | -0.05 | -0.02 | -0.04 | Upgrade
|
| Net Cash Flow | 0.89 | -3.68 | -4.02 | -3.01 | 0.33 | 1.65 | Upgrade
|
| Free Cash Flow | -1.88 | -0.73 | 1.88 | 0.57 | 0.79 | 1.46 | Upgrade
|
| Free Cash Flow Growth | - | - | 228.64% | -27.81% | -45.57% | - | Upgrade
|
| Free Cash Flow Margin | -19.59% | -7.64% | 11.10% | 2.96% | 3.95% | 6.77% | Upgrade
|
| Free Cash Flow Per Share | -0.08 | -0.03 | 0.08 | 0.03 | 0.03 | 0.06 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0 | 0 | Upgrade
|
| Cash Income Tax Paid | 0.66 | 0.66 | 0.42 | 0.21 | 0.57 | 0.21 | Upgrade
|
| Levered Free Cash Flow | -1.01 | 0.46 | 2.02 | 0.28 | 4 | -0.81 | Upgrade
|
| Unlevered Free Cash Flow | -0.99 | 0.46 | 2.02 | 0.28 | 4 | -0.81 | Upgrade
|
| Change in Net Working Capital | 0.47 | -1.19 | -1.09 | 0.7 | -6.29 | 2.28 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.